237 related articles for article (PubMed ID: 17589521)
1. Fen1 mutations result in autoimmunity, chronic inflammation and cancers.
Zheng L; Dai H; Zhou M; Li M; Singh P; Qiu J; Tsark W; Huang Q; Kernstine K; Zhang X; Lin D; Shen B
Nat Med; 2007 Jul; 13(7):812-9. PubMed ID: 17589521
[TBL] [Abstract][Full Text] [Related]
2. High risk of benzo[α]pyrene-induced lung cancer in E160D FEN1 mutant mice.
Wu Z; Lin Y; Xu H; Dai H; Zhou M; Tsao S; Zheng L; Shen B
Mutat Res; 2012 Mar; 731(1-2):85-91. PubMed ID: 22155171
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers.
Singh P; Yang M; Dai H; Yu D; Huang Q; Tan W; Kernstine KH; Lin D; Shen B
Mol Cancer Res; 2008 Nov; 6(11):1710-7. PubMed ID: 19010819
[TBL] [Abstract][Full Text] [Related]
4. Chemical-induced cancer incidence and underlying mechanisms in Fen1 mutant mice.
Xu H; Zheng L; Dai H; Zhou M; Hua Y; Shen B
Oncogene; 2011 Mar; 30(9):1072-81. PubMed ID: 20972458
[TBL] [Abstract][Full Text] [Related]
5. The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation.
Sun H; He L; Wu H; Pan F; Wu X; Zhao J; Hu Z; Sekhar C; Li H; Zheng L; Chen H; Shen BH; Guo Z
Oncogene; 2017 Jan; 36(2):194-207. PubMed ID: 27270424
[TBL] [Abstract][Full Text] [Related]
6. Functional regulation of FEN1 nuclease and its link to cancer.
Zheng L; Jia J; Finger LD; Guo Z; Zer C; Shen B
Nucleic Acids Res; 2011 Feb; 39(3):781-94. PubMed ID: 20929870
[TBL] [Abstract][Full Text] [Related]
7. Fen1 mutations that specifically disrupt its interaction with PCNA cause aneuploidy-associated cancer.
Zheng L; Dai H; Hegde ML; Zhou M; Guo Z; Wu X; Wu J; Su L; Zhong X; Mitra S; Huang Q; Kernstine KH; Pfeifer GP; Shen B
Cell Res; 2011 Jul; 21(7):1052-67. PubMed ID: 21383776
[TBL] [Abstract][Full Text] [Related]
8. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
[TBL] [Abstract][Full Text] [Related]
9. Flap Endonuclease 1 Mutations A159V and E160D Cause Genomic Instability by Slowing Reaction on Double-Flap Substrates.
Algasaier SI; Finger LD; Bennet IA; Grasby JA
Biochemistry; 2018 Dec; 57(50):6838-6847. PubMed ID: 30472848
[TBL] [Abstract][Full Text] [Related]
10. Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fen1 mice mutants.
Larsen E; Kleppa L; Meza TJ; Meza-Zepeda LA; Rada C; Castellanos CG; Lien GF; Nesse GJ; Neuberger MS; Laerdahl JK; William Doughty R; Klungland A
Cancer Res; 2008 Jun; 68(12):4571-9. PubMed ID: 18559501
[TBL] [Abstract][Full Text] [Related]
11. Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer.
Sato M; Girard L; Sekine I; Sunaga N; Ramirez RD; Kamibayashi C; Minna JD
Oncogene; 2003 Oct; 22(46):7243-6. PubMed ID: 14562054
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
13. The relationship between cell apoptosis dysfunction and FEN1 E160D mutation in lupus nephritis patients.
Wang J; Cao P; Qi YY; Chen XP; Ma L; Deng RR; Zhang LL; Zhao Y
Autoimmunity; 2017 Dec; 50(8):476-480. PubMed ID: 29239254
[TBL] [Abstract][Full Text] [Related]
14. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression.
Kucherlapati M; Yang K; Kuraguchi M; Zhao J; Lia M; Heyer J; Kane MF; Fan K; Russell R; Brown AM; Kneitz B; Edelmann W; Kolodner RD; Lipkin M; Kucherlapati R
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9924-9. PubMed ID: 12119409
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.
Kucherlapati M; Nguyen A; Kuraguchi M; Yang K; Fan K; Bronson R; Wei K; Lipkin M; Edelmann W; Kucherlapati R
Oncogene; 2007 Sep; 26(43):6297-306. PubMed ID: 17452984
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
18. Fen1 does not control somatic hypermutability of the (CTG)(n)*(CAG)(n) repeat in a knock-in mouse model for DM1.
van den Broek WJ; Nelen MR; van der Heijden GW; Wansink DG; Wieringa B
FEBS Lett; 2006 Oct; 580(22):5208-14. PubMed ID: 16978612
[TBL] [Abstract][Full Text] [Related]
19. [Flap endonuclease-1 and its role in the processes of DNA metabolism in eucaryotic cells].
Nazarkina ZhK; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2008; 42(3):405-21. PubMed ID: 18702299
[TBL] [Abstract][Full Text] [Related]
20. Association between the flap endonuclease 1 gene polymorphisms and cancer susceptibility: An updated meta-analysis.
Moazeni-Roodi A; Ghavami S; Ansari H; Hashemi M
J Cell Biochem; 2019 Aug; 120(8):13583-13597. PubMed ID: 30937972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
